Chargement en cours...
The promises of quantitative systems pharmacology modelling for drug development
Recent growth in annual new therapeutic entity (NTE) approvals by the U.S. Food and Drug Administration (FDA) suggests a positive trend in current research and development (R&D) output. Prior to this, the cost of each NTE was considered to be rising exponentially, with compound failure occurring...
Enregistré dans:
| Publié dans: | Comput Struct Biotechnol J |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Research Network of Computational and Structural Biotechnology
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5064996/ https://ncbi.nlm.nih.gov/pubmed/27761201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.csbj.2016.09.002 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|